The policy division of the European Society for Child and Adolescent Psychiatry (ESCAP) recently released an extensive statement on the need for “clinical, scientific, and ethical standards” in addressing children with gender dysphoria.

The authors cite research showing the long term harms of puberty blockers and emphasize the principles of non-maleficence and beneficence.

Read the statement here.